Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Internal and Emergency Medicine
Published in: Internal and Emergency Medicine 2/2009

01-04-2009 | CE - Letter to the Editor

Thyroid storm with atypical neurological signs: an unusual clinical emergence of a life-threatening event

Authors: Michelangelo Stanzani Maserati, Marco Faustini Fustini

Published in: Internal and Emergency Medicine | Issue 2/2009

Login to get access

Excerpt

Thyroid storm is a life-threatening medical emergency due to a state of severe hyperthyroidism. It complicates 1–2% of patients affected by hyperthyroidism with an overall mortality of 10–20%. Trauma, drugs, infections and hormonal stress may lead to a rapid onset of a thyroid crisis in patients with latent hyperthyroidism [1, 2]. …
Literature
1.
Burch HB, Wartofsky L (1993) Life threatening thyrotoxicosis: thyroid storm. Endocrinol Metab Clin North Am 22:263–277PubMed
2.
Karger S, Führer D (2008) Thyroid storm–thyrotoxic crisis: an update. Dtsch Med Wochenschr 133:479–484PubMedCrossRef
3.
Ravera JJ, Cervino JM, Fernandez G (1960) Two cases of Grave’s disease with signs of a pyramidal lesion. J Clin Endocrinal Metab 20:876–880
4.
5.
Melamed E, Berman M, Lavy S (1975) Posterolateral myelopathy associated with thyrotoxicosis. N Engl J Med 293:778–779PubMed
6.
Garcia CA, Fleming RH (1977) Reversible corticospinal tract disease due to hyperthyroidism. Arch Neurol 34:647–648PubMed
7.
Verhagen WIM, Schimsheimer RJ (1986) Neurologic disease and thyrotoxic storm. Electromyogr Clin Neurophysiol 26:27–32PubMed
8.
Roti E, Minelli R, Salvi M (1996) Clinical review 80: management of hyperthyroidism and hypothyroidism in the pregnant woman. J Clin Endocrinol Metab 81:1679–1682PubMedCrossRef
9.
Jarrett DRJ, Hansell DM, Zeegen R (1987) Thyroid crisis complicated by cerebral infarction. Br J Clin Pract 41:671–673PubMed
10.
Metadata
Title
Thyroid storm with atypical neurological signs: an unusual clinical emergence of a life-threatening event
Authors
Michelangelo Stanzani Maserati
Marco Faustini Fustini
Publication date
01-04-2009
Publisher
Springer Milan
Published in
Internal and Emergency Medicine / Issue 2/2009
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-008-0218-z

Other articles of this Issue 2/2009

Internal and Emergency Medicine 2/2009 Go to the issue

CE - Letter to the Editor

25 years of the antiphospholipid syndrome: lights and shadows on the primary prophylaxis of asymptomatic patients with confirmed positivity of antiphospholipid antibodies

CE - Letter to the Editor

An atypical vascular case of Behçet’s disease and consequent treatment

IM - Review

Evidence-Based Knowledge Management: an approach to effectively promote good health-care decision-making in the Information Era

CE - Letter to the Editor

A beneficial effect of 3-year spironolactone therapy supplementing atenolol therapy on the remodeling of atria and ventricles in a patient with permanent atrial fibrillation

IM - Original Article

Brain natriuretic peptide as a preclinical marker of chronic pulmonary hypertension in patients with pulmonary embolism

EM - Review

Emergency reversal of antithrombotic treatment
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits